Valaris slides as Q1 loss and revenue drop outweigh near-decade-high backlog
Valaris shares are sliding after the company reported Q1 2026 results showing revenue fell 25% year over year to about $465 million and a GAAP loss of $0.24 per share. Despite total backlog rising to roughly $4.9 billion, investors are focusing on weaker near-term earnings/cash flow and uncertainty from limited forward commentary amid the pending Transocean deal.
1) What happened
Valaris is down sharply in Tuesday trading after posting first-quarter 2026 financials that highlighted a weaker near-term earnings profile. The company reported total operating revenue of about $465 million (down roughly 25% from the prior year period) and a net loss, with diluted loss per share around $0.24. (tradingview.com)
2) Why the stock is moving
The move appears driven by a reset in expectations after the print: revenue contracted materially, losses persisted, and investors are weighing near-term operational and cost pressures against longer-dated positives. The filing and results commentary also flagged that Middle East disruptions increased downtime/insurance and operating costs, adding to near-term noise for offshore drillers with exposure in the region. (tradingview.com)
3) The offsetting positive (and why it didn’t help today)
Valaris emphasized contracting momentum, saying it added more than $500 million of backlog since the prior quarter and lifted total backlog to roughly $4.9 billion, a level it described as the highest in nearly a decade. While that improves forward revenue visibility, today’s tape is reacting more to the current-quarter earnings and cash-flow trajectory than to multi-year backlog headlines. (marketscreener.com)
4) What to watch next
Near-term trading may stay headline-driven because the company has reduced its usual earnings-event communication as it works through the pending all-stock transaction with Transocean. Investors are likely to focus on contract start timing for rigs returning to work later in 2026, any incremental backlog wins or schedule changes, and regulatory/shareholder milestones tied to the transaction. (marketscreener.com)